Light the Night and Walk for Cures

The Leukemia & Lymphoma Society's (LLS) Light The Night Walk is an annual event to raise funds for cures. It’s the nation’s night to pay tribute and bring hope to thousands of patients and their families.


Funds raised through Light The Night Walk support the work of hundreds of the world’s best and brightest researchers in their search for better therapies and cures for leukemia, lymphoma and myeloma.


Anyone can take part—children, adults and seniors are all welcome. This is a casual Walk with no fitness requirements.


Why walk?


Now in it's 10th year, Light The Night is celebrating a Decade of Difference. During this time:


• Nearly half a million patients and their caretakers have called the LLS Information Resource Center and received critical information about blood cancers, therapy options and issues surrounding treatment and survival.


• Nearly $40 million was disbursed to patients through the LLS Patient Assistance program to help them get the treatment they needed to fight their cancer.
• Over 100,000 patients and family members found comfort and hope through LLS First Connection and Family Support Groups.


• $425 million was given to more than 400 scientists searching for cures and improved treatments for patients.


For more information about the 2009 Light The Night Walk events, please visit www.lightthenight.org

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap